Management of juvenile diabetes through an add-on Ayurveda drugs: A case study

Author:

Limbachiya Vedanshi1,Bhinde Sagar M1

Affiliation:

1. Kaumarbhritya Department, Institute of Teaching & Research in Ayurveda, Jamnagar, Gujarat, India

Abstract

Abstract The prevalence of juvenile diabetes is increasing day-by-day. As of date, no other than insulin therapy is available as a treatment for type 1 diabetes. In Ayurveda, type 1 diabetes can be correlated with Madhumeha, which is Vataja Prameha, and with Sahaja Prameha, which occurs due to Beej Dosha. These conditions are supposed to be Asadhya (incurable) and Anushangi (long-standing); the holistic approach with Rasayana Aushadha and Pathya Aahar Vihar may help improve the quality of life. In the study presented here, a case of a patient with juvenile diabetes, treated with Ayurveda medicine. An 8-year-old male child with type 1 diabetes was treated with Guduchyadi Vati (GV) for 3 months along with his ongoing standard of care (insulin injections). After the treatment duration of 3 months, fasting blood sugar was reduced from 230 to 110 mg/dL. Postprandial blood glucose was reduced from 312 to 125 mg/dL. Glycosylated hemoglobin and mean blood glucose levels were reduced from 14.7 and 375 to 6.8 and 148 mg/dL, respectively; C-peptide increased from 0.58 to 1.56 ng/mL. His treating physician had reduced the dose of insulin from 12 to 6 units/day. Classical symptoms of Madhumeha like Daurbalya (weakness), Kshudhavruddhi (polyphagia), Pipasatipravrutti (polydipsia), and Prabhuta Avila Mutrata (polyuria) were also relieved markedly after treatment. The addition of Ayurvedic treatment (GV) to the patient’s standard treatment protocol helped maintain his blood sugar at a normal level with reduced insulin injections and relieved major symptomatology of type 1 diabetes.

Publisher

Medknow

Reference11 articles.

1. Incidence trends for childhood type 1 diabetes in India;Kumar;Indian J Endocrinol Metab,2015

2. T cell-mediated beta cell destruction: Autoimmunity and alloimmunity in the context of type 1 diabetes;Burrack;Front Endocrinol (Lausanne),2017

3. Type 1 diabetes mellitus in pediatric age group: A rising endemic;Pasi;J Fam Med Primary Care,2022

4. Integrated approach toward juvenile diabetes;Abhirami;J Ayurveda,2022

5. Review of Nisha Amalaki - An Ayurvedic formulation of turmeric and Indian gooseberry in diabetes;Bedarkar;Wjpmr,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3